NCT02030938View on ClinicalTrials.gov

SERI® Surgical Scaffold for Soft Tissue Support in Revision Augmentation Surgery

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Subjects Requiring Revision Breast Augmentation Surgery
Interventions
DEVICE

SERI® Surgical Scaffold

Standard revision augmentation (with or without implant exchange) with the adjunctive use of SERI® Surgical Scaffold placed intra- or extra-capsularly.

Trial Locations (5)

48084

Somerset Plastic Surgery, Troy

63110

Washington University School of Medicine, St Louis

92037

Mofid Plastic Surgery, La Jolla

94114

Kind Chang Plastic Surgery - California Pacific Medical Center, San Francisco

98043

Plastic Surgery Clinic, Mountlake Terrace

All Listed Sponsors
lead

Sofregen Medical, Inc.

INDUSTRY

NCT02030938 - SERI® Surgical Scaffold for Soft Tissue Support in Revision Augmentation Surgery | Biotech Hunter | Biotech Hunter